Skip to content
ZR2 Bioenergy logo

ZR2 Bioenergy

506640 BSE
₹121.40

Close ·

P/E
72.69
View as Markdown
MCP
Close 2 Nov 2026 ₹121.40 −224.40 −64.9% 1Y
Start ₹345.80

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
0.70%
Debt to Equity
0.00
EPS (TTM)
₹1.67
Book Value
₹88.70
Market Cap
—
P/E (TTM)
72.69
P/B
1.37
ROE
0.72%
Dividend Yield
0.08%
EBITDA
−₹68.00 L
52W High
₹369.00
52W Low
₹90.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

36 Poor

Data confidence 93/100

Category scores

Quality
26
Poor
Returns, margins, earnings quality 22% weight
Valuation
28
Poor
Cheap vs sector & own history 24% weight
Growth
1
Poor
Sales & profit trajectory 9% weight
Financial Health
71
Strong
Solvency, leverage, coverage 9% weight
Momentum
36
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Earnings include an other income of Rs.1.83 Cr.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1270
OscillatorsBearish270
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
44.68
Neutral
MACD (12,26,9)
−2.56
Bearish
SMA (50)
125.32
Bearish
SMA (200)
138.88
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3YIrregular period
1Y−100.00%

Net profit

Net profit growth by window
3YIrregular period
1YTiny base

Operating cash flow

Operating cash flow growth by window
3YIrregular period
1YTurned negative

Operating margin· change in pp

Operating margin growth by window
3YIrregular period
1YNo sales

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹1.16 Cr
Mar 2025₹1.49 Cr
Mar 2026₹0.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹0.39 Cr
Mar 2025₹0.09 Cr
Mar 2026₹1.00 Cr

Quarterly Results

₹ Cr
506640 quarterly results, ₹ crore
Particulars Sep 2021Dec 2021Jun 2022Sep 2022Dec 2022Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0.06
0.05
0.07
0.06
0.09
0.28
0.2
0.13
0.26
0.07
0.21
0.17
Operating Profit
−0.06
−0.05
−0.07
−0.06
−0.09
−0.28
−0.2
−0.13
−0.26
−0.07
−0.21
−0.17
Other Income
0.07
0.02
0.02
0.05
0.06
0.03
0.45
0.46
0.55
0.42
0.44
0.42
Interest
0
0
0
0
0
0
0
0
0
0
0
0.01
Depreciation
0
0
0
0
0
0.02
0.02
0.02
0.01
0.15
0.03
0.03
PBT
0.01
−0.03
−0.05
−0.01
−0.03
−0.27
0.23
0.31
0.28
0.2
0.2
0.21
Tax %
0%
0%
0%
0%
0%
0%
47.83%
0%
0%
−15%
0%
0%
Net Profit
0
−0.03
−0.05
−0.01
−0.03
−0.26
0.11
0.31
0.27
0.23
0.2
0.22
EPS (₹)
0
−0.19
−0.31
−0.06
−0.19
−0.73
0.31
0.87
0.76
0.64
0.13
0.14

Profit & Loss

₹ Cr
506640 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2025Mar 2026TTM
Sales
1.16
1.49
0
0
Expenses
1.11
1.87
0.68
0.71
Operating Profit
0.05
−0.38
−0.68
−0.71
OPM %
4.31%
−25.5%
—
—
Other Income
0.27
0.64
1.87
1.83
Interest
0
0.01
0
0.01
Depreciation
0
0.04
0.21
0.22
PBT
0.32
0.21
0.98
0.89
Tax %
−21.88%
52.38%
−3.06%
—
Net Profit
0.39
0.09
1
0.92
EPS (₹)
2.44
0.25
0.63
1.67
Div. Payout %
0%
0%
0%
—

Balance Sheet

₹ Cr
506640 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2025Mar 2026
Equity Capital
—
0.36
0.36
Reserves
—
139
140
Borrowings
—
0
0
Other Liabilities
—
0.15
1.34
Total Liabilities
—
140
141
Fixed Assets
—
0.5
0.31
CWIP
—
119
120
Investments
—
0
0
Other Assets
—
20.04
20.83
Total Assets
—
140
141

Cash Flow

₹ Cr
506640 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2025Mar 2026
Operating
0.91
31.05
−0.69
Investing
0.19
−117
0.48
Financing
0
100
−0.04
Net Cash Flow
1.1
14.78
−0.25
Free Cash Flow
0.91
−88.44
−1.92
CFO/EBITDA
1,780
−8,171
97

Ratios

506640 financial ratios, annual
Particulars Mar 2022Mar 2025Mar 2026
Debtor Days
—
4.9
—
Inventory Days
—
0
—
Cash Conversion Cycle
—
4.9
—
Working Capital Days
—
162
—
ROCE %
—
—
0.7%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view ZR2 Bioenergy insights

58 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Mar 2026

  • Promoters 61.00%
  • Public 37.29%
  • Others 1.65%
  • DIIs 0.06%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about ZR2 Bioenergy

What does ZR2 Bioenergy Ltd do?
Incorporated in 1939, ZR2 Bioenergy Limited is in the business of Ethanol and bioenergy products.
Where is ZR2 Bioenergy Ltd (ZR2) listed?
ZR2 Bioenergy Ltd trades under code 506640 on the BSE.
Which sector does ZR2 Bioenergy Ltd belong to?
ZR2 Bioenergy Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the PE ratio of ZR2 Bioenergy Ltd?
ZR2 Bioenergy Ltd trades at a PE ratio of 72.69 as of 2 Nov 2026, on earnings per share of ₹1.67, against a book value of ₹88.7 per share.
What is the 52-week high and low of ZR2 Bioenergy Ltd?
Over the last 52 weeks ZR2 Bioenergy Ltd has traded between ₹90 and ₹369 as of 2 Nov 2026.
Does ZR2 Bioenergy Ltd pay dividends?
ZR2 Bioenergy Ltd has a dividend yield of 0.08%.
What is the Return on Equity (ROE) of ZR2 Bioenergy Ltd?
ZR2 Bioenergy Ltd reported a return on equity of 0.72%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1939, ZR2 Bioenergy Limited is in the business of Ethanol and bioenergy products.

Website gujchemdistillers.com
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506640.md for ZR2 Bioenergy Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month